A group of scientists from the Max Planck Institute in Germany conducted experiments on mice, and a cocktail test of two properties with regeneration properties.
The results showed that the age of animals increased by 30 percent, and there was also an improvement in public health. The results of the study were Published In the Journal of Nature Age.
The study used Rapamycin and Treetinib medications, which are used to treat various forms of cancer. It has already been shown that Rapamycin extends her life in the clinical trials of the animal, and Trametinib previously showed similar effects on fruit flies. However, its effects on large animals were doubtful.
Scientists have studied how each drug affected the age of mice, whether individually or community. Rapamisin extended mice by 17 to 18 percent, while Tramitinib added 7 to 16 percent. Together, its effect was much powerful, and an increase of age by 26 to 35 percent.
More importantly, the additional life that the animals received did not come with any health deterioration. Complex treatment slows the growth of liver and spleen tumors and reduces chronic inflammation in various organs, including the brain and kidneys.
The treated mice were more active in old age and weight, as well as had a more stable heart function compared to the control group.
While the results of the study are encouraging, scientists warn against expecting a significant increase in average human life. The focus is on improving the quality of life in old age.
The author of the study and the genetic Linda Bartridge emphasizes that medications can help people stay in good health and active age. Human trials are expected to start in the coming years.
